Endocr Pract. 2018 Dec;24(12):1073-1085. doi: 10.4158/EP-2018-0379. Epub 2018 Oct 5.
The management of diabetic patients undergoing elective abdominal surgery continues to be unsystematic, despite evidence that standardized perioperative glycemic control is associated with fewer postoperative surgical complications. We examined the efficacy of a pre-operative diabetes optimization protocol implemented at a single institution in improving perioperative glycemic control with a target blood glucose of 80 to 180 mg/dL.
Patients with established and newly diagnosed diabetes who underwent elective colorectal surgery were included. The control group comprised 103 patients from January 1, 2011, through December 31, 2013, before protocol implementation. The glycemic-optimized group included 96 patients following protocol implementation from January 1, 2014, through July 31, 2016. Data included demographic information, blood glucose levels, insulin doses, hypoglycemic events, and clinical outcomes (length of stay, re-admissions, complications, and mortality).
Patients enrolled in the glycemic optimization protocol had significantly lower glucose levels intra-operatively (145.0 mg/dL vs. 158.1 mg/dL; P = .03) and postoperatively (135.6 mg/dL vs. 145.2 mg/dL; P = .005). A higher proportion of patients enrolled in the protocol received insulin than patients in the control group (0.63 vs. 0.48; P = .01), but the insulin was administered less frequently (median [interquartile range] number of times, 6.0 [2.0 to 11.0] vs. 7.0 [5.0 to 11.0]; P = .04). Two episodes of symptomatic hypoglycemia occurred in the control group. There was no difference in clinical outcomes.
Improved peri-operative glycemic control was observed following implementation of a standardized institutional protocol for managing diabetic patients undergoing elective colorectal surgery.
HbA1c = glycated hemoglobin A1c; IQR = interquartile range.
尽管有证据表明标准化围手术期血糖控制可减少术后手术并发症,但糖尿病患者择期腹部手术的管理仍不系统。我们研究了在一家机构实施术前糖尿病优化方案对改善围手术期血糖控制(目标血糖 80 至 180mg/dL)的效果。
纳入接受择期结直肠手术的已确诊和新诊断糖尿病患者。对照组包括方案实施前(2011 年 1 月 1 日至 2013 年 12 月 31 日)的 103 例患者。血糖优化组包括方案实施后(2014 年 1 月 1 日至 2016 年 7 月 31 日)的 96 例患者。数据包括人口统计学信息、血糖水平、胰岛素剂量、低血糖事件和临床结局(住院时间、再入院、并发症和死亡率)。
血糖优化方案组患者术中(145.0mg/dL 比 158.1mg/dL;P=0.03)和术后(135.6mg/dL 比 145.2mg/dL;P=0.005)血糖水平显著降低。方案组接受胰岛素治疗的患者比例明显高于对照组(0.63 比 0.48;P=0.01),但胰岛素使用频率较低(中位数[四分位间距]使用次数,6.0[2.0 至 11.0]比 7.0[5.0 至 11.0];P=0.04)。对照组发生 2 例症状性低血糖。两组临床结局无差异。
实施管理择期结直肠手术糖尿病患者的标准化机构方案后,围手术期血糖控制得到改善。